• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

08/09/2018/by CAPTIS

Wright Medical shares rise on Q2 earnings Beat

Shares in Wright Medical (NSDQ:WMGI) rose today in pre-market…
08/09/2018/by CAPTIS

Saudi Arabia updates clearance policy for medical device shipments

08/08/2018/by CAPTIS

Viveve wins FDA nod to continue Viveve II trial

08/08/2018/by CAPTIS

InVivo Therapeutics shares down as losses grow in Q2 earnings release

08/08/2018/by CAPTIS

Envoy Medical’s hearing implant wearers can get MRIs

08/08/2018/by CAPTIS

Boston Scientific to submit last FDA PMA module for Lotus Edge aortic valve this month

08/08/2018/by CAPTIS

Second Sight shares down despite Q2 earnings beat

08/08/2018/by CAPTIS

Myomo shares down on Q2 miss

08/08/2018/by CAPTIS

Medpace prices $248m secondary offering

08/08/2018/by CAPTIS

Valeritas tops sales, earnings estimates in Q2

08/08/2018/by CAPTIS

ARTMS’ system may ease cost, shortage of valuable radioisotopes

ARTMS Products (Vancouver, B.C) has won the CE mark for its first-in-class,…
08/08/2018/by CAPTIS

Staar Surgical prices $68m offering

08/08/2018/by CAPTIS

Corindus shares fall on Q2 earnings release

08/08/2018/by CAPTIS

Ocular Therapeutix beats The Street with Q2 results

08/08/2018/by CAPTIS

Tandem reels in $115m from public offering

08/08/2018/by CAPTIS

Endo shares soar on Street-beating Q2

08/08/2018/by CAPTIS

Report: Smiths may abandon talks of merger with ICU Medical

08/08/2018/by CAPTIS

Boston Scientific inks $160m deal for peripheral stent maker Veniti

08/08/2018/by CAPTIS

Mylan lowers outlook after Q2 earnings, sales miss estimates

08/07/2018/by CAPTIS

CryoLife shares up on street-beating Q2 revenues

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

BOA

September 25 - September 28ICC Birmingham

We Suggest:

CHF Solutions shares down on Q2 earnings release

0 Comments
/
08/07/2018
Shares in CHF Solutions (NSDQ:CHFS) fell today after…
Read more
https://www.captis.com/wp-content/uploads/2018/08/chf-solutions-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-07 11:53:432018-08-09 06:24:14CHF Solutions shares down on Q2 earnings release

TransEnterix shares fall despite Street-beating Q2

0 Comments
/
08/07/2018
Shares in TransEnterix (NYSE:TRXC) fell today after the…
Read more
https://www.captis.com/wp-content/uploads/2018/08/transenterix-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-07 11:27:152018-08-09 06:24:28TransEnterix shares fall despite Street-beating Q2

Si-Bone touts iFuse implant coverage across 23 insurers

0 Comments
/
08/07/2018
Si-Bone today touted that its iFuse implant system has…
Read more
https://www.captis.com/wp-content/uploads/2018/08/si-bone-ifuse-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-07 10:39:132018-08-09 06:24:24Si-Bone touts iFuse implant coverage across 23 insurers

Dentsply Sirona shares fall as Q2 earnings show growing losses

0 Comments
/
08/07/2018
Shares in Dentsply Sirona (NSDQ:XRAY) have significantly…
Read more
https://www.captis.com/wp-content/uploads/2018/08/dentsply-sirona-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-07 10:17:162018-08-09 06:24:21Dentsply Sirona shares fall as Q2 earnings show growing losses

Senseonics launches Eversense implantable glucose monitor

0 Comments
/
08/07/2018
Senseonics (NYSE:SENS) said today that its Eversense…
Read more
https://www.captis.com/wp-content/uploads/2018/08/senseonics-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-07 10:13:452018-08-09 06:24:17Senseonics launches Eversense implantable glucose monitor

Marken opens clinical trial logistics hub in Melbourne, Australia

0 Comments
/
08/02/2018
The new location joins Sydney and Brisbane as the third Australian…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:492018-08-02 01:37:49Marken opens clinical trial logistics hub in Melbourne, Australia

Novelion’s Myalepta gets European approval to treat generalized and partial lipodystrophy

0 Comments
/
08/02/2018
Myalepta has been approved as an adjunct to diet, as a replacement…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:472018-08-02 01:37:48Novelion’s Myalepta gets European approval to treat generalized and partial lipodystrophy

Emergent starts phase 1 trial of Zika virus immune globulin therapeutic

0 Comments
/
08/02/2018
ZIKV-IG was granted Fast Track designation by the U.S. Food and…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:452018-08-02 01:37:46Emergent starts phase 1 trial of Zika virus immune globulin therapeutic

Pfizer secures European approval for Xeljanz to treat ulcerative colitis

0 Comments
/
08/02/2018
The marketing authorization has been granted for Xeljanz10 mg…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:442018-08-02 01:37:44Pfizer secures European approval for Xeljanz to treat ulcerative colitis

Amgen breaks ground on $200m biomanufacturing facility in US

0 Comments
/
08/02/2018
The company expects to invest up to $200m in the approximately…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:422018-08-02 01:37:43Amgen breaks ground on $200m biomanufacturing facility in US

Daiichi Sankyo signs licensing deal with Glycotope for Gatipotuzumab ADC

0 Comments
/
08/02/2018
The deal combines Daiichi Sankyo’s ADC technology with…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:402018-08-02 01:37:41Daiichi Sankyo signs licensing deal with Glycotope for Gatipotuzumab ADC

Marken opens customer solutions center in Russia

0 Comments
/
08/02/2018
In addition, Marken has begun their unique hybrid service for…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:382018-08-02 01:37:39Marken opens customer solutions center in Russia

RedHill’s RHB-104 meets primary endpoint in phase III Crohn’s disease study

0 Comments
/
08/02/2018
The company has announced the positive top-line safety and efficacy…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:372018-08-02 01:37:37RedHill’s RHB-104 meets primary endpoint in phase III Crohn’s disease study

Lilly extends cancer research collaboration with Dana-Farber

0 Comments
/
08/02/2018
Since 2015, scientists from Lilly and Dana-Farber have been working…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:352018-08-02 01:37:36Lilly extends cancer research collaboration with Dana-Farber

Progenics’ Azedra gets FDA approval for rare adrenal gland tumors

0 Comments
/
08/02/2018
The approval is for the intravenous use of the Azedra injection…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-02 01:37:332018-08-02 01:37:34Progenics’ Azedra gets FDA approval for rare adrenal gland tumors

Masimo Q2 posts beat-and-raise Q2

0 Comments
/
08/01/2018
Masimo (NSDQ:MASI) today posted second quarter earnings…
Read more
https://www.captis.com/wp-content/uploads/2018/08/masimo-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-01 13:21:092018-08-02 01:41:28Masimo Q2 posts beat-and-raise Q2

ConMed posts Street-beating Q2

0 Comments
/
08/01/2018
ConMed (NSDQ:CNMD) today posted second quarter earnings…
Read more
https://www.captis.com/wp-content/uploads/2018/08/conmed-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-01 12:58:432018-08-02 01:41:03ConMed posts Street-beating Q2

K2M posts mixed-bag Q2

0 Comments
/
08/01/2018
K2M (NSDQ:KTWO) today posted second quarter earnings…
Read more
https://www.captis.com/wp-content/uploads/2018/08/k2m-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-01 12:38:572018-08-02 01:40:59K2M posts mixed-bag Q2

Globus Medical whales on Wall Street’s Q2 expectations

0 Comments
/
08/01/2018
Globus Medical (NYSE:GMED) today whaled on the consensus…
Read more
https://www.captis.com/wp-content/uploads/2018/08/Globus-medical-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-01 12:33:242018-08-02 01:40:56Globus Medical whales on Wall Street’s Q2 expectations

AtriCure posts Street-beating Q2, raises sales outlook

0 Comments
/
08/01/2018
AtriCure (NSDQ:ATRC) today posted second quarter earnings…
Read more
https://www.captis.com/wp-content/uploads/2018/08/atricure-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-08-01 12:21:242018-08-02 01:40:49AtriCure posts Street-beating Q2, raises sales outlook
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
K2M, Inc. Jobs
K2M, Inc. Jobs
@K2MIncJobs

Congratulations to Lane Major for his recent promotion to Chief Operating Officer @K2MInc! Read more: bit.ly/LaneMajor pic.twitter.com/iDXk…

reply retweet favorite
12:45 pm · 03/31/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
José Luis Maçãs
José Luis Maçãs
@zeluismacas

Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…

reply retweet favorite
11:29 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
SOFCOT
SOFCOT
@sofcot_ortho

Thème du congrès SOFCOT 2018 : "La Décision Médicale" pic.twitter.com/hJT5…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
EUROSPINE
EUROSPINE
@EUROSPINESoc

Exactly 3 weeks left to submit your abstract for #EUROSPINE2018 - #deadline 1 March 2018 #research #spine #SpineResearch #spineSurgery #SpinalDisorder #ScientificPaper #BasicScience #ClinicalResearch #PublishResearch @EurSpineJournal buff.ly/2ExMQ7e pic.twitter.com/Fx2Q…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
Olea Medical
Olea Medical
@OleaMedical

Throughout the week, we are in #Bruges alongside Prof. Jan Casselman for an #Erasmus course program on #ENT imaging, held at the Oud Sint-Jan congress centre. The training of around 170 radiologists is based on images from our post-processing solution Olea Sphere®V3.0. #MRI pic.twitter.com/KSUU…

reply retweet favorite
11:24 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
Olea Medical
Olea Medical
@OleaMedical

#ArtificialIntelligence is currently in the center of all discussions, medical #imaging including. What will be impacted, notably in #MSK imaging? Listen to the answer of Pr Cotten from Lille’s CHRU : youtu.be/93nLXGX4hEk

reply retweet favorite
5:20 pm · 01/24/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Did you know our IRIS technology may reduce ureteral injury rates by up to an estimated 49%? Protect your patient & reduce risk in the OR! pic.twitter.com/koeJ…

reply retweet favorite
5:16 pm · 01/24/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Wishing Medtronic co-founder Earl Bakken a very happy 94th birthday. Best wishes to you, Earl! pic.twitter.com/zdDa…

reply retweet favorite
5:20 pm · 01/11/2018 ·
Retweeted by CAPTIS
Twitter
CAPTIS
CAPTIS
@CaptisCorp

European investment group LSP closes $330m healthcare fund captis.com/?p=36537

reply retweet favorite
11:54 pm · 12/16/2017
Twitter
CAPTIS
CAPTIS
@CaptisCorp

CHF Solutions closes $18m Series F round captis.com/?p=36109

reply retweet favorite
10:22 am · 12/05/2017
Twitter
CAPTIS
CAPTIS
@CaptisCorp

BD tacks another extension onto Bard tender offer captis.com/?p=36138

reply retweet favorite
10:21 am · 12/05/2017
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Boston Scientific takes a $3B hit on latest Lotus valve delay captis.com/?p=36199

reply retweet favorite
10:21 am · 12/05/2017
Twitter
Acelity
Acelity
@Acelity

Dedicated to improving the lives of #DFU patients, Acelity is happy to celebrate #WorldDiabetesDay. Wear blue today to show your support! pic.twitter.com/VBYW…

reply retweet favorite
5:11 am · 11/15/2017 ·
Retweeted by CAPTIS
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Zebra Medical Vision to host AI1 image analytics on Google Cloud captis.com/?p=35413

reply retweet favorite
5:08 pm · 11/09/2017
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Johnson & Johnson break ground on Chinese factory lnkd.in/gA9hTsu

reply retweet favorite
2:40 am · 11/05/2017
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top